Medical Biotechnology

24-25 May 2018, Ghent, Belgium
Pictures of the event, added after the event has passed ...: 
Event has passed
Corporate Partners
VAT not included
Payment options
Medical Biotechnology

"Medical Biotechnology is in an era of rapid transformation because of new disruptive technologies for early diagnosis and more effective therapeutic intervention, even in established chronic diseases,"  said Nico Callewaert of the VIB-UGent Center for Medical Biotechnology and organizing committee member of this conference. "VIB organizes this focus meeting to provide cutting edge insight delivered by top scientists from academia and industry."

During four plenary sessions the following topics will be covered:

  • biopharmaceutical technology
  • targeted delivery
  • diagnostics & biomarkers
  • vaccines

In addition to the scientific sessions there will be ample opportunities to network during the breaks, posters sessions, reception and conference dinner.

Especially for junior researchers a ‘Meet the Expert' session with Dr. Annemieke Geluk will be organized on the 24th of May. During an informal round table discussion PhD students and postdocs will have the exclusive opportunity to ask any question/advise related to their research and careers. If you are interested in joining the session, then send an e-mail to conferences@vib.be. Seating is limited.

Poster information:
Format: A0 (841 x 1189 mm / 33.1 x 46.8 in), portrait orientation

Confirmed speakers: 

Carl June

Perelman School of Medicine, UPenn, US

Michael Snyder

Center for Genomics and Personalized Medicine, Stanford University, US

Gary J. Nabel

Sanofi Global R&D, US

Danica Stanimirovic

National Research Council, CA

G. Mike Makrigiorgos

Dana-Farber/Harvard Cancer Center, US

Annemieke Geluk

LUMC Leiden, NL

Mustafa Diken

TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz, DE

Ashley Birkett

Director of PATH’s Malaria Vaccine Initiative (MVI), US

Ryan Watts

Denali Therapeutics, US

Nathalie Heuzé Vourc’h

INSERM U1100, Research Centre of Respiratory Diseases, Tours, FR

Rogier Sanders

Academic Medical Center, University of Amsterdam, NL

David Gilham

Celyad S.A., BE

John Bell

Ottawa Hospital Research Institute, CA

An Hendrix

Ghent University, BE

Jan Tavernier

VIB-UGent Center for Medical Biotechnology, BE

Florian Krammer

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, US
Submit an abstract: 
Medical Biotechnology
Abstract submission closing date: 
Monday, 26 March, 2018
Submit abstract

Day 1 - 24 May 2018

Thursday, 24 May, 2018
08:45 - 09:15
Registration & Coffee
09:15 - 09:20
Welcome by Nico Callewaert
09:20 - 12:40
AM Plenary session: Diagnostics & biomarkers

Chair: Kris Gevaert

09:20 - 10:10
Managing health and disease using big data
Michael Snyder
Center for Genomics and Personalized Medicine, Stanford University, US
Keynote speaker
10:10 - 10:45
Novel technologies for the detection of clinically relevant DNA alterations in circulating DNA
G. Mike Makrigiorgos
Dana-Farber/Harvard Cancer Center, US
Academic speaker
10:45 - 11:15
Coffee
11:15 - 11:50
Point of care diagnostics in tuberculosis and leprosy
Annemieke Geluk
LUMC Leiden, NL
Academic speaker
11:50 - 12:25
Isolation and characterization of extracellular vesicles in liquid biopsies
An Hendrix
Ghent University, BE
Academic speaker
12:25 - 12:40
Selected talk: Circulating human cytomegalovirus endogenous microRNA detection by microgel-based assay
Tania Mariastella Caputo
Istituto Italiano di Tecnlogia, IT
12:40 - 13:30
Lunch
13:30 - 14:30
Poster session
14:30 - 18:10
PM Plenary session: Targeted delivery

Chair: Erik Depla

14:30 - 15:05
AcTakines: a novel class of cancer immunotherapeutics
Jan Tavernier
VIB-UGent Center for Medical Biotechnology, BE
Academic speaker
15:05 - 15:40
Inhalation of antibody (Ab) to treat respiratory diseases (RD)
Nathalie Heuzé Vourc’h
INSERM U1100, Research Centre of Respiratory Diseases, Tours, FR
Academic speaker
15:40 - 15:55
Selected talk: Therapeutic applicability of TNF receptor-1 inhibition using small single-domain antibodies
Sophie Steeland
VIB Center for Inflammation Research, BE
15:55 - 16:25
Coffee
16:25 - 17:00
Addressing central nervous system target space using single-domain antibody technologies
Danica Stanimirovic
National Research Council, CA
Academic speaker
17:00 - 17:35
Engineering brain delivery of therapeutics for neurodegeneration
Ryan Watts
Denali Therapeutics, US
Company speaker
17:35 - 18:10
Development of oncolytic virus vaccine technology for the treatment of cancer
John Bell
Ottawa Hospital Research Institute, CA
Academic speaker
18:10 - 19:00
Reception
20:00 - 23:00
Conference dinner

Organizing Committee:

Nico Callewaert, VIB-UGent Center for Medical Biotechnology
Xavier Saelens, VIB-UGent Center for Medical Biotechnology
Erik Depla, Orionis Biosciences 
Kris Gevaert, VIB-UGent Center for Medical Biotechnology
Evy Vierstraete, PhD, VIB Science Events Manager

Day 2 - 25 May 2018

Friday, 25 May, 2018
08:45 - 09:15
Coffee
AM Plenary session: Biopharmaceutical technology

Chair: Nico Callewaert

09:15 - 10:05
Carl June
Perelman School of Medicine, UPenn, US
Keynote speaker
10:05 - 10:40
Exploiting innate immune cell recognition for CAR T cell therapy for cancer
David Gilham
Celyad S.A., BE
Company speaker
10:40 - 11:10
Coffee
11:10 - 11:45
Nanobodies – A versatile advanced therapeutic platform
Company speaker
11:45 - 12:20
The evolution of RNA-based cancer vaccines
Mustafa Diken
TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz, DE
Academic speaker
12:20 - 12:35
Selected talk: Engineering the immune system with synthetic nanomaterials
Bruno De Geest
Ghent University, BE
12:35 - 13:30
Lunch
13:30 - 14:30
Poster session
14:30 - 17:50
PM Plenary session: Vaccines

Chair: Xavier Saelens

14:30 - 15:05
Engineering native-like HIV-1 envelope trimers to induce neutralizing antibodies
Rogier Sanders
Academic Medical Center, University of Amsterdam, NL
Academic speaker
15:05 - 15:40
A hemagglutinin stalk-based universal influenza virus vaccine
Florian Krammer
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, US
Academic speaker
15:40 - 15:55
Selected talk: Spy and Snoop protein superglues to accelerate vaccine development
Mark Howarth
University of Oxford, UK
15:55 - 16:25
Coffee
16:25 - 17:00
Development of vaccines to accelerate malaria parasite elimination and eradication
Ashley Birkett
Director of PATH’s Malaria Vaccine Initiative (MVI), US
Academic speaker
17:00 - 17:50
Development of trispecific antibodies for aids and cancer
Gary J. Nabel
Sanofi Global R&D, US
Keynote speaker
17:50 - 18:00
Closing remarks by Kris Gevaert

Organizing Committee:

Nico Callewaert, VIB-UGent Center for Medical Biotechnology
Xavier Saelens, VIB-UGent Center for Medical Biotechnology
Erik Depla, Orionis Biosciences 
Kris Gevaert, VIB-UGent Center for Medical Biotechnology
Evy Vierstraete, PhD, VIB Science Events Manager

Hashtag: 
#Medbiotech18